The steatogenic alleles in PNPLA3, TM6SF2, GCKR and MBOAT7 all associated with increased risk of ICD‐defined ‘other diseases of liver’ (K76), which includes NAFLD (n = 408 455, P = 0.0075–2 × 10−12, Table S6 and Figure S4). This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.